| Systemic sclerosis: state of the art on clinical practice guidelines V Smith, CA Scirè, R Talarico, P Airo, T Alexander, Y Allanore, C Bruni, ... RMD open 4 (Suppl 1), e000782, 2019 | 131 | 2019 |
| SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients M Zen, E Fuzzi, D Astorri, F Saccon, R Padoan, L Ienna, G Cozzi, ... Journal of autoimmunity 112, 102502, 2020 | 120 | 2020 |
| IL-12 and IL-23/Th17 axis in systemic lupus erythematosus M Larosa, M Zen, M Gatto, D Jesus, E Zanatta, L Iaccarino, L Inês, A Doria Experimental Biology and Medicine 244 (1), 42-51, 2019 | 95 | 2019 |
| Therapy of scleroderma renal crisis: State of the art E Zanatta, P Polito, M Favaro, M Larosa, P Marson, F Cozzi, A Doria Autoimmunity reviews 17 (9), 882-889, 2018 | 72 | 2018 |
| Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment E Zanatta, P Polito, G Famoso, M Larosa, E De Zorzi, E Scarpieri, F Cozzi, ... Experimental Biology and Medicine 244 (2), 120-131, 2019 | 69 | 2019 |
| Outcomes of limited cutaneous systemic sclerosis patients: results on more than 12,000 patients from the EUSTAR database C Frantz, D Huscher, J Avouac, E Hachulla, A Balbir-Gurman, ... Autoimmunity reviews 19 (2), 102452, 2020 | 59 | 2020 |
| Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases E Zanatta, C Colombo, G D’amico, T d’Humières, C Dal Lin, F Tona International journal of molecular sciences 20 (22), 5563, 2019 | 58 | 2019 |
| Balneotherapy in chronic inflammatory rheumatic diseases—a narrative review F Cozzi, L Ciprian, M Carrara, P Galozzi, E Zanatta, A Scanu, P Sfriso, ... International journal of biometeorology 62, 2065-2071, 2018 | 57 | 2018 |
| Effectiveness, tolerability, and safety of belimumab in patients with refractory SLE: a review of observational clinical-practice-based studies F Trentin, M Gatto, M Zen, L Maddalena, L Nalotto, F Saccon, E Zanatta, ... Clinical Reviews in Allergy & Immunology 54, 331-343, 2018 | 56 | 2018 |
| The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort MG Lazzaroni, E Marasco, C Campochiaro, J DeVries-Bouwstra, ... Rheumatology 60 (11), 5028-5041, 2021 | 51 | 2021 |
| The role of plasma exchange in the management of autoimmune disorders E Zanatta, M Cozzi, P Marson, F Cozzi British journal of haematology 186 (2), 207-219, 2019 | 45 | 2019 |
| Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review. C Bruni, G De Luca, MG Lazzaroni, E Zanatta, G Lepri, P Airò, L Dagna, ... European Journal of Internal Medicine 78, 17-25, 2020 | 41 | 2020 |
| Systemic sclerosis: recent insight in clinical management E Zanatta, V Codullo, J Avouac, Y Allanore Joint Bone Spine 87 (4), 293-299, 2020 | 41 | 2020 |
| Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database Y Allanore, S Bozzi, A Terlinden, D Huscher, C Amand, C Soubrane, ... Arthritis research & therapy 22, 1-11, 2020 | 36 | 2020 |
| Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association E Zanatta, G Famoso, F Boscain, R Montisci, E Pigatto, P Polito, ... Autoimmunity Reviews 18 (2), 177-183, 2019 | 35 | 2019 |
| Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition C Bruni, MH Buch, DE Furst, G De Luca, A Djokovic, RB Dumitru, A Giollo, ... Journal of Scleroderma and Related Disorders 7 (1), 24-32, 2022 | 34 | 2022 |
| COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study C Ferri, D Giuggioli, V Raimondo, L Dagna, V Riccieri, E Zanatta, ... The Lancet Rheumatology 3 (3), e166-e168, 2021 | 31 | 2021 |
| Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case–control study F Cozzi, E Pigatto, M Rizzo, M Favaro, E Zanatta, S Cardarelli, L Riato, ... Clinical rheumatology 32, 679-683, 2013 | 28 | 2013 |
| Evaluation of right ventricular function performed by 3D-echocardiography in scleroderma patients E Pigatto, D Peluso, E Zanatta, P Polito, P Miatton, K Bourji, LP Badano, ... Reumatismo 66 (4), 259-263, 2014 | 27 | 2014 |
| Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study C Campochiaro, G De Luca, MG Lazzaroni, E Zanatta, SL Bosello, ... Rheumatology 59 (12), 3731-3736, 2020 | 26 | 2020 |
